Dr. John Gaitanis Appointed Chair of Autism Committee
The pediatric neurologist will now lead the federal group tasked with coordinating autism research and support strategy.
Updated on Sept. 18, 2026 in Autism
Live Poll
Should government advisory committees be led by federal employees rather than outside experts?
Health Secretary Robert F. Kennedy Jr. has appointed Dr. John Gaitanis as the new chair of the Interagency Autism Coordinating Committee. The committee advises the government on federal research and strategy regarding autism spectrum disorder.
Why it matters
The change aims to strengthen the focus on federal efforts and the implementation of strategic plans for autism care and research. By appointing a federal representative, officials intend to improve coordination across the various agencies involved in national autism initiatives.
The Interagency Autism Coordinating Committee is an advisory body composed of 21 federal members and 20 outside public members. The group is responsible for overseeing the federal strategic plan, which previously included recommendations to adopt the term profound autism for those with high support needs.
The players
Dr. John Gaitanis
A pediatric neurologist and the director of the National Institutes of Health's child health institute.
Robert F. Kennedy Jr.
The Health Secretary of the United States who oversees federal health policy and agency appointments.
Dr. Sylvia Fogel
A committee member and former chair who continues to support the committee's scientific and coordination priorities.
The details
The committee functions by gathering diverse input from both federal agencies and non-government stakeholders to shape federal health policy. Dr. Gaitanis, currently the director of the National Institutes of Health's child health institute, will oversee these coordination efforts. Dr. Sylvia Fogel, who has chaired the committee since January 2026, will transition into an assisting role focused on meeting preparation and information gathering while remaining a member.
Timeline
January 2026: Dr. Sylvia Fogel began her term as chair of the committee.
August 2026: Dr. John Gaitanis was appointed director of the NICHD.
September 18, 2026: Dr. John Gaitanis assumed the role of committee chair.
Health Landscape
This leadership change reflects an ongoing effort to align federal advisory bodies with high-level health strategy. The appointment directly impacts the oversight of the Interagency Autism Coordinating Committee's strategic plan, which governs federal investment and research priorities.
This administrative change does not immediately alter clinical guidelines or individual treatment plans. If you are managing autism care, consider discussing how current federal research priorities might affect available local services with your physician.
The takeaway
Leadership changes at the federal level help shape the future direction of national autism policy and research investments. Patients and families can track committee progress by reviewing the public meeting minutes typically posted following official advisory sessions.
Further reading
Find more updates and resources on the Autism page.
Live Poll
Should government advisory committees be led by federal employees rather than outside experts?
